Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TRANsplantation vs reSECTion After Conversion Therapy for Initially Unresectable

NCT07607873 is registered in ClinicalTrials.gov with Niguarda Hospital as lead sponsor.

NCT NCT07607873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07607873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TRANsplantation vs reSECTion After Conversion Therapy for Initially Unresectable
Lead sponsor
Niguarda Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
June 1, 2026
Completion date
June 15, 2031
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal liver metastases